Company ProfilePremium

CAMBREX CORPORATION

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
CAMBREX CORPORATION - Healthcare showcase

Year Founded & Workforce

1981

2,000 Employees

Industry

Healthcare

Services

Drug Substance (High Potency APIs)
C

CAMBREX CORPORATION Employee Contacts

55 verified contactsNames, job titles, seniority and locations

View Employee Contacts

CAMBREX CORPORATION Overview

Company Headquarters: New Jersey, US

Founded: 1981

Workforce: ~ 2,000

Company Working: Cambrex Corporation is actively engaged in the manufacturing and distribution of small molecules. The company operates in business segments namely, drug substance, drug products, and analytical services. In the drug substance segment, the company offers services such as custom manufacturing, specialist technologies, solid-state science, material characterization, and generic APIs including High potency APIs. It operates through more than 13 EMEA, HPFBI, FDA, and DEA (CI-CV) approved manufacturing facilities located in North America and Europe.

Strategy

Cambrex Corporation focuses on the ongoing expansion of its business through strategic collaborations, including new technologies, additional products, organizational strength, and geographic presence. Moreover, it also concentrates on delivering innovative solutions and improving product quality through research & development.

Company Snapshot

$433.9M

Revenue

2,000

Employees

1981

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

  • Strong brand reputation
  • Diversified businesses
  • Integration of products and services
  • State of art manufacturing facilities

Weaknesses

  • Limited presence outside the US and Europe

Opportunities

  • Partnership with other players to diversify its business
  • Research & development of advanced technologies

Threats

  • Fluctuation in currency rates
  • Stringent government regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
April 2019ExpansionCambrex Corporation completed the construction of 6,000 sq. ft. highly potent API manufacturing facility in Iowa. It will help the company to increase its production capacity and cater to the needs of US customers

Product Offering

  • CAMBREX CORPORATION
    • Drug Substance (High Potency APIs)

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 433.9 Mn in 2015 to USD 526 Mn in 2017.
CAMBREX CORPORATION — By Business Segment
Series (USD Mn)201520162017
Sales433.9491.5526

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.